N-Acetyl Semax Amidate

Also known as: NA-Semax-Amidate · Ac-Semax-NH2

Related-compound evidence only

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

This analog adds an acetyl group at the N-terminus and converts the C-terminal acid to an amide. Both changes are part of the molecule’s identity.

Evidence position

The exact compound has a registry record, but the human literature cited for Semax concerns a different molecule. Grade D prevents that parent evidence from being presented as direct analog evidence.

What the record does not establish

The common Semax core does not prove equivalent stability, exposure, receptor activity, safety or outcomes. A commercial sample also requires lot-linked identity and purity testing.

Sources

01
N-acetyl Semax amidate compound recordPubChem
Shows
Registry identity, formula and sequence for the terminally modified analog
Does not show
Chemical identity does not establish biological activity or product quality
02
Semax in ischemic-stroke rehabilitationPubMed
Shows
Human research on parent Semax
Does not show
Does not test the N-acetyl, C-terminal-amidated analog

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBCHEM / IDENTITY